MULTICOMPONENT ASO AGENT FOR INTRACELLULAR OVEREXPRESSION AND MUTATION RECOGNITION
Ultrasensitive-selective DNA nanomachine for Teaticular Germ Cell Tumors detection
Antisense Oligonucleotides-Mediated Gene Silencing for Cancer Therapy
Nour M., Drozd V.S., Lemeshko E.A., Tafran L., Salimova A.A., Kulikova A.V., Eldeeb A.A. RNase H-dependent DNA thresholder modulated by cancer marker concentration. Chemical Communications. 2024. Vol. 60. No. 33. pp. 4427-4430.
Patra C.K., Smirnov V.V., Drozd V.S., Hussein Z., Rybalko D.S., Kozlova A.V., Nour M., Zemerova T.P., Kolosova O.S., Kalnin A.Y., El-Deeb A. Towards the Development of a DNA Automaton: Modular RNA-cleaving Deoxyribozyme Logic Gates Regulated by miRNAs. Analyst. 2024. Vol. 149. No. 6. pp. 1947-1957.
Dubovichenko M.V., Batsa M., Bobkov G.A., Vlasov G.S., El-Deeb A.A., Kolpashchikov D.M. Multivalent DNAzyme agents for cleaving folded RNA. Nucleic Acids Research. 2024. Vol. 52. No. 10. pp. 5866–5879.
DESIGN AND DEVELOPMENT OF MARKER ACTIVATED NANOMACHINES USING DNA ORIGAMI FOR CANCER THERAPY
Hussein Z., Golovina L.A., Alaji M., Nour M., Kolpashchikov D.M., Komissarov A.B., El-Deeb A. Enhancing Sensitivity in Nucleic Acid Detection via Collaborative Multiple Catalytic Cores in DNAzyme Nanomachines. ChemBioChem. 2024. No. in press. pp. e202400572.
Dubovichenko M.V., Nnanyereugo V., Bobkov G.A., El-Deeb A.A., Kolpashchikov D.M. COMPARISON OF ANTISENSE OLIGONUCLEOTIDES, DNAZYMES AND THEIR BIVALENT FORMS IN RNASE H DEPENDENT CLEAVAGE OF FOLDED RNA. не указано. 2024. Vol. не указан. No. не указан. pp. in press.
Nedorezova D.D., Dubovichenko M.V., Eldeeb A.A., Nur M.A., Bobkov G.A., Ashmarova A.I., Kalnin A.J., Kolpashchikov D.M. Cleaving Folded RNA by Multifunctional DNAzyme Nanomachines. Chemistry - A European Journal. 2024. Vol. 30. No. 40. pp. e202401580.
OPTIMIZATION OF AFFINITY AND STABILITY OF SELECTED APTAMER FOR BSA
Dubovichenko M.V., Nedorezova D.D., Patra C., Drozd V.S., Andrianov V.S., Ashmarova A.I., Nnanyereugo V., El-Deeb A.A., Kolpashchikov D.M. Marker-dependent cleavage of RNA by binary (split) DNAzyme (BiDz) and binary DNA machines (BiDNM). ChemBioChem. 2024. No. in press. pp. e202400665.
DESIGN AND DEVELOPMENT OF A PROTECTIVE DNA NANO-TUBE USING DNA ORIGAMI FOR ENHANCED CANCER GENE THERAPY
Nedorezova D.D., Dubovichenko M.V., Kalnin A.Y., Nour M.A., Eldeeb A.A., Ashmarova A.I., Kurbanov G.F., Kolpashchikov D.M. Cleaving Folded RNA with DNAzyme Agents. ChemBioChem. 2024. Vol. 25. No. 1. pp. e202300637.
Selective DNA-machine for SNP Detection in KRAS
Patra C., Eldeeb A.A. Thresholding DNA nanomachine as a highly cooperative and efficient enzyme-like system for controlled RNA cleavage. ChemMedChem. 2023. Vol. 18. No. 7. pp. e202300040.
Hussein Z., Nour M., Kozlova A.V., Kolpashchikov D.M., Komissarov A., El-Deeb A. DNAzyme Nanomachine with Fluorogenic Substrate Delivery Function: Advancing Sensitivity in Nucleic Acid Detection. Analytical Chemistry. 2023. Vol. 95. No. 51. pp. 18667-18672.
Nour M.A., Kulikova A.V., Wanjohi J., El-Deeb A. Distinguishing High from Low Concentrations of RNA Cancer Marker: Five-Input DNAzyme Thresholding Gate. ChemistrySelect. 2023. Vol. 8. No. 48. pp. e202303011.
Prospects of using binary deoxyribozymes as a biosensor for quantitative analysis of oligonucleotide concentrations
АКТИВАЦИЯ БИНАРНЫМИ АНТИСМЫСЛОВЫМИ ОЛИГОНУКЛЕОТИДАМИ ДЕГРАДАЦИИ МРНК-МИШЕНИ С ПОМОЩЬЮ KRAS ТРАНСКРИПТА В КЛЕТОЧНОЙ ЛИНИИ K562 *
ДНК-МАШИНЫ НА ОСНОВЕ БИНАРНЫХ ДЕЗОКСИРИБОЗИМОВ КАК ПЕРСПЕКТИВНЫЙ ИНСТРУМЕНТ БЕЗАМПЛИФИКАЦИОННОЙ ДИАГНОСТИКИ SARS-CoV-2
Development and optimization of high affinity oncogene-specific DNA aptamers for human cancer cells binding
Genotyping of Cancer-associated KRAS Mutation by Deoxyribozyme Based 4-arms DNA Machine
МНОГОЯДЕРНАЯ ДНК-МАШИНА НА ОСНОВЕ БИНАРНЫХ ДЕЗОКСИРИБОЗИМОВ ДЛЯ БЕЗАМПЛИФИКАЦИОННОЙ ДЕТЕКЦИИ SARS-COV-2
РАЗРАБОТКА МОДИФИЦИРОВАННОГО БИНАРНОГО АНТИСМЫСЛОВОГО НУКЛЕОТИДА ДЛЯ РАСЩЕПЛЕНИЯ ЦЕЛЕВОЙ мРНК В ПРИСУТСТВИИ ОНКОМАРКЕРА
Towards DNA-robot for Auto Diagnosis and Cancer Treatment
Использование триазиниламидофосфата для внутриклеточной доставки АСО и сложных ДНК-конструкций//OpenBio
Cancer cell death induced by antisense oligonucletides
MULTICORE DNA-MACHINE BASED ON BINARY DEOXYRIBOZYME FOR AMPLIFICATION-FREE DETECTION OF SARS-COV-2
ГИБЕЛЬ КЛЕТОК АДЕНОКАРЦИНОМЫ ЯИЧНИКА ПОД ВОЗДЕЙСТВИЕМ АНТИСМЫСЛОВЫХ ОЛИГОНУКЛЕОТИДОВ
DEPENDENCE OF THE AFFINITY OF OLIGONUCLEOTIDES ON CHEMICAL MODIFICATIONS AND THE LENGTH OF NUCLEOTIDE SEQUENCES
ADVANCING DNA AUTOMATION: MIRNAS-REGULATED “NOT-GATE” LOGIC ELEMENTS BASED ON DEOXYRIBOZYME DNA MACHINES
ДНК-МАШИНА С НЕСКОЛЬКИМИ КАТАЛИТИЧЕСКИМИ ЦЕНТРАМИ НА ОСНОВЕ ДЕЗОКСИРИБОЗИМА ДЛЯ БЕЗАМПЛИФИКАЦИОННОГО ДЕТЕКТИРОВАНИЯ SARS-COV-2
Development of DNA-based Machines for Selective Detection of Cancer-associated RNA
ANTISENSE OLIGONUCLEOTIDES RELEASING CASSETTE FOR CANCER THERAPY
РАЗРАБОТКА СЕЛЕКТИВНОЙ ДНК КОНСТРУКЦИИ С ПОРОГОВОЙ ЛОГИКОЙ ДЛЯ РАСЩЕПЛЕНИЯ МАТРИЧНОЙ РНК GFP
ОСОБЕННОСТИ ДИЗАЙНА БИНАРНЫХ АНТИСМЫСЛОВЫХ ОЛИГОНУКЛЕОТИДНЫХ АГЕНТОВ (БИАСО) ДЛЯ МАРКЕР-ЗАВИСИМОЙ АКТИВАЦИИ ТЕРАПЕВТИЧЕСКОЙ ФУНКЦИИ
Rubel M.S., Zablotskay S., Pokatova O., El-Deeb A.A., Ateiah M.G., Gorbenko D.A., Shkodenko L., Kolpashchikov D.M. DNA-nanomachines for nucleic acid detection. Bioinformatics of Genome Regulation and Structure/Systems Biology (BGRS/SB-2022) Novosibirsk, 04-08 июля 2022 г.. 2022. pp. 355-356.
INVESTIGATION OF INTRACELLULAR DELIVERY OF THERAPEUTIC NUCLEIC ACIDS WITH THE HELP OF LIPID CONJUGATES AND DNA NANOSTRUCTURES
El-Deeb A., Zablotskaya S., Rubel M.S., Nour M., Kozlovskaya L., Shtro A., Komissarov A., Kolpashchikov D.M. Toward a Home Test for COVID-19 Diagnosis: DNA Machine for Amplification-Free SARS-CoV-2 Detection in Clinical Samples. ChemMedChem. 2022. Vol. 17. No. 20. pp. e202200382.
Drozd V.S., Eldeeb A.A., Kolpashchikov D.M., Nedorezova D.D. Binary antisense oligonucleotide agent for cancer marker-dependent degradation of targeted RNA. Nucleic Acid Therapeutics. 2022. Vol. 32. No. 5. pp. 412-420.
КОНСТРУКЦИИ НА ОСНОВЕ НУКЛЕИНОВЫХ КИСЛОТ ДЛЯ ШИРОКОГО СПЕКТРА ПРИМЕНЕНИЙ
Binary antisense constructs modulated by the concentration of cancer markers
ANTENNA-EQUIPPED DEOXYRIBOZYME-BASED DNA MACHINE FOR ULTRA -SENSITIVITY DETECTION OF SARS-COV-2 RNA
NUCLEIC ACID BASED CONSTRUCTIONS FOR WIDE RANGE OF APPLICATIONS
ДНК МАШИНА С НЕСКОЛЬКИМИ КАТАЛИТИЧЕСКИМИ ЦЕНТРАМИ НА ОСНОВЕ ДЕЗОКСИРИБОЗИМА ДЛЯ БЕЗАМПЛИФИКАЦИОННОЙ ДЕТЕКЦИИ SARS-COV-2
DETECTION OF NUCLEIC ACID BASED CANCER MARKERS INSIDE THE CELL
AN shRNA RELEASING DNA NANOSTRUCTURE WITH ONCOMARKER-DEPENDENT ACTIVATION
MARKER INDUCED CLEAVAGE OF A TARGETED mRNA USING THE ANTISENSE OLIGONUCLEOTIDE-RELEASING CASSETTE (ASO-RC)
РАЗРАБОТКА ЛОГИЧЕСКОГО ВЕНТИЛЯ «INHIBIT GATE» НА ОСНОВЕ БИНАРНОГО ДЕЗОКСИРИБОЗИМА
DESIGN OF A DNA MACHINE BASED ON SHRNA FOR MARKER-DEPENDENT RNA INTERFERENCE
ИССЛЕДОВАНИЕ БИНАРНЫХ АНТИСМЫСЛОВЫХ ОЛИГОНУКЛЕОТИДОВ СПЕЦИФИЧНЫХ К ОДНОНУКЛЕОТИДНОМУ ПОЛИМОРФИЗМУ МАРКЕРНОЙ ПОСЛЕДОВАТЕЛЬНОСТИ
ANTENNA-EQUIPPED DEOXYRIBOZYME MACHINE FOR ULTRA-SENSITIVITY AMPLIFICATION-FREE DETECTION OF SARS-COV-2 RNA
Gomes de Oliveira A., Dubovichenko M.V., Eldeeb A.A., Wanjohi J., Zablotskaya S., Kolpashchikov D.M. RNA-Cleaving DNA Thresholder Controlled by Concentrations of miRNA Cancer Marker. ChemBioChem. 2021. Vol. 22. No. 10. pp. 1750-1754.
COOPERATIVITY FOR CANCER TREATMENT: A THRESHOLDING DNA LOGIC GATE THAT IS ACTIVE AT HIGH CONCENTRATIONS OF CANCER MARKER RNA
DNA Machine for SARS-COV-2 Detection in the Clinical Samples
DNA-constructs based on binary antisense technology towards selective gene therapy
BINARY ANTISENSE OLIGONUCLEOTIDES FOR ONCOMARKER-DEPENDENT TARGET RNA DEGRADATION
DISTINGUISHING HIGH FROM LOW CONCENTRATIONS OF RNA CANCER MARKER: 5-INPUT BINARY DEOXYRIBOZYME THRESHOLDING GATE
ADVANCED DNA MACHINE FOR THE AMPLIFICATION FREE DETECTION OF SARS-HCOV-2 IN THE CLINICAL SAMPLES
DEVELOPMENT OF PROTECTIONS FOR ANTISENSE AND BINARY ANTISENSE AGENTS
DNA-constructs based on binary antisense technology towards selective gene therapy
Эльдиб А.А., Заблоцкая С.С., Рубель М.С., Комиссаров А.Б., Колпащиков Д.М. ДНК-машина для определения nCOV-SARS-2019. Современные достижения химико-биологических наук в профилактической и клинической медицине: сборник научных трудов Всероссийской научно-практической конференции с международным участием (СПб, 3декабря 2020г.). 2020. Т. Часть 1. С. 358-363.
ДНК-машина для определения nCOV-SARS-2019
ДНК-машина для определения nCOV-SARS-2019